USD 0.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.29 Million USD | -26.83% |
2022 | 1.76 Million USD | 42.76% |
2021 | 1.23 Million USD | -35.54% |
2020 | 1.92 Million USD | 8.01% |
2019 | 1.77 Million USD | -20.05% |
2018 | 2.22 Million USD | 4.56% |
2017 | 2.12 Million USD | -0.4% |
2016 | 2.13 Million USD | -13.83% |
2015 | 2.48 Million USD | 25.66% |
2014 | 1.97 Million USD | -33.64% |
2013 | 2.97 Million USD | 524.71% |
2012 | 476.18 Thousand USD | 336.13% |
2011 | 109.18 Thousand USD | 172.96% |
2010 | 40 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 FY | 1.29 Million USD | -26.83% |
2023 Q1 | - USD | -100.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 Q3 | 430.22 Thousand USD | 38.47% |
2022 Q4 | 740.51 Thousand USD | 72.12% |
2022 FY | 1.76 Million USD | 42.76% |
2022 Q1 | 287.74 Thousand USD | -2.73% |
2022 Q2 | 310.7 Thousand USD | 7.98% |
2021 Q4 | 295.81 Thousand USD | 8.49% |
2021 Q2 | 362.21 Thousand USD | 17.4% |
2021 Q1 | 308.54 Thousand USD | -12.55% |
2021 FY | 1.23 Million USD | -35.54% |
2021 Q3 | 272.66 Thousand USD | -24.72% |
2020 Q3 | 809.38 Thousand USD | 91.28% |
2020 Q4 | 352.81 Thousand USD | -56.41% |
2020 FY | 1.92 Million USD | 8.01% |
2020 Q1 | 337.27 Thousand USD | -7.41% |
2020 Q2 | 423.13 Thousand USD | 25.46% |
2019 Q4 | 364.26 Thousand USD | -9.88% |
2019 Q3 | 404.21 Thousand USD | -24.53% |
2019 FY | 1.77 Million USD | -20.05% |
2019 Q2 | 535.59 Thousand USD | 12.55% |
2019 Q1 | 475.86 Thousand USD | -3.58% |
2018 Q1 | 334.16 Thousand USD | 9.86% |
2018 Q4 | 493.51 Thousand USD | -41.06% |
2018 Q3 | 837.36 Thousand USD | 49.18% |
2018 Q2 | 561.31 Thousand USD | 67.98% |
2018 FY | 2.22 Million USD | 4.56% |
2017 Q1 | 495.52 Thousand USD | 73.96% |
2017 FY | 2.12 Million USD | -0.4% |
2017 Q2 | 678.98 Thousand USD | 37.02% |
2017 Q3 | 650.51 Thousand USD | -4.19% |
2017 Q4 | 304.16 Thousand USD | -53.24% |
2016 Q4 | 284.84 Thousand USD | -33.81% |
2016 FY | 2.13 Million USD | -13.83% |
2016 Q1 | 636.59 Thousand USD | -5.92% |
2016 Q3 | 430.37 Thousand USD | -40.34% |
2016 Q2 | 721.39 Thousand USD | 13.32% |
2015 Q1 | 582.52 Thousand USD | 292.37% |
2015 FY | 2.48 Million USD | 25.66% |
2015 Q3 | 646.23 Thousand USD | 12.34% |
2015 Q4 | 676.65 Thousand USD | 4.71% |
2015 Q2 | 575.27 Thousand USD | -1.25% |
2014 Q2 | 637.32 Thousand USD | 2.57% |
2014 Q1 | 621.34 Thousand USD | -22.99% |
2014 FY | 1.97 Million USD | -33.64% |
2014 Q4 | 148.46 Thousand USD | -73.82% |
2014 Q3 | 567.03 Thousand USD | -11.03% |
2013 Q3 | 536.53 Thousand USD | -48.87% |
2013 Q4 | 806.82 Thousand USD | 50.38% |
2013 FY | 2.97 Million USD | 524.71% |
2013 Q1 | 582.09 Thousand USD | 71.66% |
2013 Q2 | 1.04 Million USD | 80.26% |
2012 FY | 476.18 Thousand USD | 336.13% |
2012 Q1 | 28.53 Thousand USD | 51.53% |
2012 Q2 | 44.77 Thousand USD | 56.94% |
2012 Q3 | 63.77 Thousand USD | 42.44% |
2012 Q4 | 339.09 Thousand USD | 431.69% |
2011 Q4 | 18.82 Thousand USD | 141.14% |
2011 FY | 109.18 Thousand USD | 172.96% |
2011 Q1 | 37.09 Thousand USD | 0.0% |
2011 Q2 | 45.45 Thousand USD | 22.52% |
2011 Q3 | 7808.00 USD | -82.82% |
2010 FY | 40 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | -74.783% |
IR-Med Inc. | 4.89 Million USD | 73.548% |
Polarean Imaging plc | 12.24 Million USD | 89.426% |
Medical Supply International USA, Inc. | 1.32 Million USD | 1.963% |
Avitar, Inc. | 3.56 Million USD | 63.732% |
AVITA Medical, Inc. | 80.77 Million USD | 98.397% |
Manhattan Scientifics, Inc. | 703 Thousand USD | -84.15% |
Össur hf. | 396.18 Million USD | 99.673% |
Zecotek Photonics Inc. | 3.46 Million USD | 62.6% |
QHSLab, Inc. | 961.65 Thousand USD | -34.62% |
Wellstar International, Inc. | 1.79 Million USD | 27.866% |
Össur hf. | 396.18 Million USD | 99.673% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 94.056% |
Escalon Medical Corp. | 5.25 Million USD | 75.345% |
Aurora Spine Corporation | 8.65 Million USD | 85.047% |
BrainsWay Ltd. | 28.01 Million USD | 95.379% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 9.56 Million USD | 86.465% |
Hamilton Thorne Ltd. | 33.57 Million USD | 96.144% |
Vivos Inc. | 2.78 Million USD | 53.551% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.877% |
Kelyniam Global, Inc. | 2.27 Million USD | 43.102% |
REMSleep Holdings, Inc. | 1.01 Million USD | -27.557% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | -197.262% |
Nanomix Corporation | 8.36 Million USD | 84.529% |
Theraclion SA | 7.43 Million USD | 82.599% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Positron Corporation | 1 Million USD | -28.522% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | 58.38% |
Lombard Medical, Inc. | 30.29 Million USD | 95.726% |
ALR Technologies Inc. | 6.33 Million USD | 79.568% |
Stratec SE | 46.32 Million USD | 97.205% |
Vycor Medical, Inc. | 1.27 Million USD | -1.499% |
Heart Tronics, Inc. | 14.46 Million USD | 91.047% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -974.107% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -527.16% |
SANUWAVE Health, Inc. | 14.15 Million USD | 90.852% |
VMS Rehab Systems, Inc. | 63.63 USD | -2034440.311% |
Guided Therapeutics, Inc. | 3.49 Million USD | 62.938% |
Ingen Technologies, Inc. | 1.88 Million USD | 31.221% |
Odyssey Group International, Inc. | -14.26 Million USD | 109.078% |
United American Healthcare Corporation | 59 Thousand USD | -2094.2% |
ECGI Holdings, Inc. | 407.48 Thousand USD | -217.7% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | -103.971% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | 23.649% |
Urologix, Inc. | 10.09 Million USD | 87.172% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -2.473% |
Nexeon MedSystems Inc. | 5.94 Million USD | 78.236% |
SS Innovations International, Inc. | 21.38 Million USD | 93.945% |
Qualis Innovations, Inc. | 230.24 Thousand USD | -462.271% |
Smith & Nephew plc | 3.46 Billion USD | 99.963% |
NIOX Group Plc | 22.27 Million USD | 94.189% |
Fuse Medical, Inc. | 10.35 Million USD | 87.492% |
Broncus Holding Corporation | 38.15 Million USD | 96.607% |
Brain Scientific Inc. | 9.66 Million USD | 86.602% |
Pressure BioSciences, Inc. | 10.3 Million USD | 87.435% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -2032.818% |